发展环境

2020年全球体外诊断(IVD)市场将达747亿美元

发布时间:2014-06-10 

联合市场调研(Allied Market Research,AMR)近日发布一份最新报告指出,在未来7年内,全球体外诊断市场(IVD)将以5.34%的年度复合增长率(CAGR)增长,并在2020年达到747亿美元。该市场在2013年的价值为533亿美元。

不断增加的公众健康意识、据成本效益的诊断解决方案、准确且更快速的检测结果是驱动全球IVD市场增长的一些因素。此外,对能够及早和准确诊断各种疾病的先进设备的需求,也日益刺激全球市场的增长。

根据报告内容,北美占据了大部分的市场份额,在预测期间内,预计将以4.02%CAGR增长,并在2020年达到301亿美元。而亚洲则具有最快的增长率,CAGR7.49%

按应用划分,IVD市场可细分为感染性疾病、糖尿病、癌症、心脏病、自身免疫性疾病、肾脏病、药物检测、HIV/AIDS检测。其中,目前排名位列第一二位的感染性疾病和HIV/AIDS将继续保持其地位至2020年。

而在最终用途方面,鉴于POCTPoint of Care Testing,即时诊断)设备的日益普及,家用诊断市场预计将成为最快的增长区域。

该份报告指出,IVD市场的主角主要包括:雅培、罗氏诊断、西门子、强生、AlereArkray、拜耳、碧迪公司(Becton Dickinson)、生物梅里埃(Biomerieux)、丹纳赫(Danaher)和希森美康(Sysmex)。

英文原文:In Vitro Diagnostics Market Set to Grow to $74.7B By 2020

Posted in IVD by Arundhati Parmar on June 5, 2014
A new report predicts that the global in vitro diagnostics market will grow to $74.7 billion by 2020 fueled by increased awareness and demand for equipment that speeds up accurate diagnosis.

The global in vitro diagnostics market is forecast to grow to $74.7 billion by the year 2020, according to a new market report.

The report, published by Allied Market Research, shows that the market was worth $53.3 billion last year, and as such is expected to grow at a compound annual growth rate of 5.34% in the next seven years.

Increasing public awareness about healthcare, cost effective diagnostic solutions, accurate and faster test results are some of the factors driving the growth of the IVD market globally, according to the report. Further, high demand for advanced equipment that can diagnose various diseases early and accurately is spurring market growth throughout the world.

North America accounts for the lions share of the market and is expected to grow to $30.1 billion by 2020 at a CAGR of 4.02%. But Asia accounts for the fastest growing region with a CAGR of 7.49% in the forecasted period.

By application, the IVD market can be divided into infectious disease, diabetes, cancer, cardiology, autoimmune diseases, nephrology, drug testing, and HIV/AIDS. Of these, infectious diseases, followed by HIV/AIDS testing are top two generators of revenue in the market currently and are expected to maintain their positions through 2020.

In terms of end use, the at-home diagnostics market is expect to be the fastest area of growth given the increasing availability of point-of-care testing devices.

The top global players in this market are: Abbot Laboratories, Roche Diagnostics, Siemens, Johnson & Johnson, Alere, Arkray, Bayer AG, Becton Dickinson & Company, Biomerieux, Danaher and Sysmex, according to the report.

联系方式

地址:中国(上海)自由贸易试验区 外高桥美约路222号五楼501室

 

邮 编:200131

传 真:58661522

电 话:58661516

邮 箱:mdta@www.girlzgonewilder.com

相关链接

©2018 上海浦东医疗器械贸易行业协会

沪ICP备19039930号 沪公网安备31019002000210号 互联网药品信息服务资格证书编号:(沪)-非经营性-2010-0068

技术支持:维程教育

在线快3-下载